Pharmacogenetic Information in Clinical Guidelines: The European Perspective
- Swen, J.J.
- Nijenhuis, M.
- Rhenen, M. van
- Boer-Veger, N.J. de
- Buunk, A.M.
- Houwink, E.J.
- Mulder, H.
- Rongen, G.A.
- Schaik, R.H. van
- Weide, J. van der
- Wilffert, B.
- Deneer, V.H.
- Guchelaar, H.J.
Publication date
January 2018
DOIAbstract
Surveys among pharmacists and physicians show that these healthcare professionals have successfully adopted the concept of pharmacogenomics (PGx).(1-3) In addition, patients are willing to consent to participate in PGx implementation studies.(4) However, the surveys also show that healthcare professionals do not frequently order or recommend a PGx test.(1,2) Among others, a frequently perceived hurdle for clinical uptake of PGx is the availability of guidelines translating PGx test results into clinical actions for individual patients.(5,6)
Add to ORKG